AYOXXA – the Translational Proteomics Company

Understanding complex biology from bench to bedside


Facilitating LUNARIS™ multiplex biomarker detection using the CYTENA C-WASH™ plate washer and liquid dispenser

Read more

Kit finder

The right biomarker panel in just a few clicks

Read more

Inflammation/Cytokines Complement

LUNARIS™ Human 4-Plex Complement Kit

LUNARIS™ Human 4-Plex Complement Kit

Read more


Analysis of synovial biomarkers with a multiplex protein microarray in patients with PJI undergoing revision arthroplasty of the hip or knee joint

Read more

Coronavirus Update


Read more

Press Release

AYOXXA receives fresh capital for commercial growth

Read more


Growing life science company seeks new talent and fresh ideas

Read more


LUNARIS™ Multiplex Protein Analysis

Our LUNARIS™ Portfolio vastly augments your insights into a single sample. Designed to deliver top-quality data on multiple proteins in as little as 3 µL of sample, our current LUNARIS™ Kits quantify secreted and soluble markers of inflammation and immune responses implicated in ophthalmic and other diseases.

Combined with the LUNARIS™ Reader and dedicated analysis software, our panels are validated for various clinically relevant sample types.

LUNARIS technology

The power of our proprietary LUNARIS™ Technology lies in its elegant simplicity, which we leveraged to engineer an integrated and scalable multiplex protein analysis system, with a dedicated reader and intuitive image-based readout and data analysis.

The result is a platform that delivers transparent assay outcomes, superior data quality, workflow flexibility, and conservation of precious samples. You quantify as many as 12 biomarkers in just 3 µL of sample. You adapt the system to your throughput needs. You decide when to perform readout and how to evaluate each data point.

LUNARIS™ embodies our vision of success in translational proteomics. Validated for various biofluids, tissue samples, and cell culture, LUNARIS™ opens new opportunities in multiplex biomarker quantification to drive advances from model to man, from lab to clinic, from data to insight.

Research that has jump-started enthusiasm for and use of our LUNARIS™ Platform spans various areas and focuses on translating discoveries into clinical applications.

Ophthalmology – Working with leading scientists, we have gained expertise in handling and analyzing ocular fluid samples from patients and model systems for biomarker validation, drug development, and possible therapeutic monitoring of ophthalmic diseases.

Model-to-man translation – Our panel development strategy aims to facilitate the elucidation of human inflammation physiology based on learnings from cellular and animal models.

Immuno-oncology – Research collaborations in immune responses and immuno-oncology have highlighted the relevance of our LUNARIS™ Technology in this field, and opened protein multiplexing opportunities for basic research and clinical applications.

Realizing our vision of enabling success in translational research requires a tenacious team of skilled and imaginative people. That is who we are at AYOXXA Biosystems GmbH. Guided by an experienced management and Supervisory Board, our teams in Cologne (Germany), Singapore and Boston (USA) strive to create and offer high-performance solutions for translational proteomics.

Still have any questions? Ask us!

AYOXXA Newsletter

Be the first to know! Get regular news on AYOXXA and our products.

* The following fields are required for signing up our newsletter.

Connect with AYOXXA

Follow news and developments on these networks and platforms.